EUVIMED · CrossrefZeitschrift
Current Drug Target -Infectious Disorders
ISSN 1568-0053 · Bentham Science Publishers Ltd.
Neueste Artikel
Identification of Inhibitors of Bacterial Enoyl-Acyl Carrier Protein Reductase
Candida and Candidiasis: The Cell Wall as a Potential Molecular Target for Antifungal Therapy
Resistance to HIV-1 Entry Inhibitors
Chitin Synthesis as a Target for Antifungal Drugs
1,3-beta-Glucan Synthase: A Useful Target for Antifungal Drugs
Molecular Mechanisms of Antibiotic Resistance in Gram-Positive Pathogens.
Rational Drug Design of DNA Oligonucleotides as HIV Inhibitors
Bisphosphonates as Chemotherapeutic Agents Against Trypanosomatid and Apicomplexan Parasites.
4 -C-Substituted-2 -Deoxynucleosides A Family of Antiretroviral Agents Which are Potent Against Drug-Resistant HIV Variants.
The Strategy of Immunologic Control of HIV-1 with Structured Treatment Interruptions (STIs)
West Nile Virus Vaccine.
Bacterial Ribosomal Subunit Synthesis A Novel Antibiotic Target.
Preface
Use of T Cell Epitopes for Vaccine Development
Vaccines Against Polysaccharide Antigens
Bacterial Carriers and Virus-Like-Particles as Antigen Delivery Devices: Role of Dendritic Cells in Antigen Presentation
Preface
Novel Adjuvant Systems
Recent Developments in Vaccine Delivery Systems
History of Vaccines and Positioning of Current Trends
Vaccines for Parasitic Diseases
New Approaches for Antigen Discovery, Production and Delivery: Vaccines for Veterinary and Human Use
HIV-1 Integration as a Target for Antiretroviral Therapy: A Review
Antifibrogenic Therapies in Chronic HCV Infection
Adhesion Mechanisms of the Lyme Disease Spirochete, Borrelia burgdorferi
The Emerging New Generation of Antibiotic: Ketolides
The HCMV Chemokine Receptor US28 is a Potential Target in Vascular Disease
The Discovery of Linezolid, the First Oxazolidinone Antibacterial Agent
E. Coli MurG: A Paradigm for a Superfamily of Glycosyltransferases
Unexploited Viral and Host Targets for the Treatment of Human Immunodeficiency Virus Type 1 Infection
EUVIMED